Moreover, a recent study reported that the novel drug AU-15330, which specifically inhibits SMARCA4/BRG1, SMARCA2/hBRM and PBRM1/BAF180, has potent inhibitory functions on enhancer-addicted PCa [13]. This evidence concerns the gene PBRM1 and posterior cortical atrophy.